These results were reflected in in vivo experiments, reaffirming the central role of PERK in glioma growth, whereas epidermal growth factor (EGF) exogenous addition partially rescued apoptotic events mediated by PERK loss (Figure 2) [130]. This evidence concerns the gene EIF2AK3 and central nervous system cancer.